Question on Modeling out PP&E - Proceeds from Sale of PP&E

When modeling out a PP&E schedule, should you include proceeds from sale of PP&E? I know this would affect the ending balance of PP&E for that period so would you need to show that historically? And would if you do have to include it would you just straight line it for the projected periods?

7 Comments
 
Most Helpful

Yes, you'd reduce PP&E balance by the sale amount.

On balance sheet, PP&E is recorded at its net amount (sometimes you'll see Gross PP&E along with an accumulated D&A to get net PP&E) Therefore,

Net PP&E, end of period = Net PP&E, beginning of period (simply equal to Net PP&E, end of last period) + PP&E-related Capex during the period (maintenance + growth + acquisition) - D&A for the period - asset sales and PP&E write-downs during the period.

The actual cash proceeds from the sale would accrue to Cash Flow from Investing as a positive amount. Cash has no place on the PP&E schedule.

Array
 

great thank you for the answer. In terms of forecasting PP&E what would I do with the sale of PP&E going forward? Would I just assume it is 0 or would I straight line the previous years sale amount or would I take a % of total PP&E?

 

If historically the company has been doing sales of PP&E (not sure for what reason...I'd find this strange), then put the average historical amount. Usually it should just be zero.

Array
 

Took a quick look at their 10-K Cash Flow from Investing section. Seems like they do a 500-900mm of capex (PP&E) additions every year but their sales of PP&E number is very low (2-40mm). This is expected, as with any business, because sale of PP&E is obviously not their core business as a defense industry contractor (plus if it were truly their core business it would be recorded under the income statement revenues flowing into CFO net income). Therefore, just put down the average of the past 3 years as the future projected sales proceeds of PP&E. Or you can just zero them out completely; this tiny amount compared to net PP&E base of 3bn+ or $30bn annual revenue is negligible.

Array
 

Excepturi sed fuga voluptatibus et ea sapiente quidem. Molestiae occaecati sit adipisci voluptatem voluptates exercitationem et.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.3%
  • BMO Capital Markets 12 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan 01 97.1%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (15) $434
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (79) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
Secyh62's picture
Secyh62
99.0
4
kanon's picture
kanon
99.0
5
Betsy Massar's picture
Betsy Massar
98.9
6
dosk17's picture
dosk17
98.9
7
CompBanker's picture
CompBanker
98.9
8
GameTheory's picture
GameTheory
98.9
9
DrApeman's picture
DrApeman
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”